Cytosorbents Corporation (CTSO) vs PAVmed Inc. (PAVM)
- Cytosorbents Corporation CTSO 4.58 +4.09%
- PAVmed Inc. PAVM 2.00 +1.52%
Cytosorbents Corporation and PAVmed Inc. are both Medical Devices companies. PAVmed Inc. is the larger, with a market value of $15.8M against $13.9M — 1.1× the size. Cytosorbents Corporation grew revenue faster over the last twelve months: 3.07% against −89.0%. Cytosorbents Corporation has the higher net margin (−48.9% vs −18,417.9%) and the lower return on invested capital (−66.9% vs −54.5%). Across the 16 metrics below, Cytosorbents Corporation leads on 12 and PAVmed Inc. on 4.
Valuation
Profitability
| Metric | CTSO | PAVM | Medical Devices median |
|---|---|---|---|
| Gross margin | 71.61% | (221.43%) | 57.16% |
| Operating margin | (34.74%) | (23,841.07%) | (18.70%) |
| Net margin | (48.94%) | (18,417.86%) | (19.62%) |
| Free cash flow margin | (25.32%) | (6,948.21%) | (7.24%) |
| Return on equity | (336.17%) | (216.61%) | (13.14%) |
| Return on assets | (42.38%) | (49.05%) | (19.72%) |
| Return on invested capital | (66.90%) | (54.50%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack